What is NDC 60219-1467?

60219-1467 is the product NDC for Medroxyprogesterone Acetate, Medroxyprogesterone acetate 150 mg/mL injection, suspension, listed with the FDA by Amneal Pharmaceuticals NY LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

Amneal Pharmaceuticals NY LLC, NDC labeler code 60219. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Medroxyprogesterone Acetate?

39 other product NDCs are listed under this name.

Medroxyprogesterone Acetate NDC 60219-1467

NDC codes

FDA NDC Directory

Product NDC (as listed)60219-1467Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60219-1467Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60219-1467-1	6021914670160219146701	1 VIAL in 1 CARTON (60219-1467-1) / 1 mL in 1 VIALMarketed from Jun 10, 2025
60219-1467-2	6021914670260219146702	25 VIAL in 1 CARTON (60219-1467-2) / 1 mL in 1 VIALMarketed from Jun 10, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Medroxyprogesterone Acetate
Generic name (nonproprietary): medroxyprogesterone acetate
Active ingredients: Medroxyprogesterone acetate — 150 mg/mL
Dosage form: Injection, Suspension
Route: Intramuscular
Labeler: Amneal Pharmaceuticals NY LLCNDC labeler code 60219
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210227
Marketing start: Jun 10, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Progesterone Congeners (Chemical structure)
Identifiers: Product ID 60219-1467_b18868d1-e830-4990-a0f2-66210a783d39SPL ID b18868d1-e830-4990-a0f2-66210a783d39SPL set ID a80560e1-96dd-4380-b3e1-d52719ccdd4bRxCUI 1000126UNII C2QI4IOI2GUPC 0360219146716
Pharmacologic class: Progestin

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeMed-Code curated

J1050 — Injection, medroxyprogesterone acetate, 1 mg

Billing unit: 1 mg. Units on the claim = dose given ÷ 1 mg.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N460219146701 followed by a unit qualifier and the quantity

Package 60219-1467-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 7, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Medroxyprogesterone acetate injectable suspension is indicated for use by females of reproductive potential to prevent pregnancy. Limitations of Use : The use of medroxyprogesterone acetate injectable suspension is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate [see Dosage and Administration (2.1) and Warnings and Precautions (5.1) ]. Medroxyprogesterone acetate injectable suspension is a progestin indicated for use by females of reproductive potential to prevent pregnancy. ( 1 ) Limitations of Use: The use of medroxyprogesterone acetate injectable suspension is not recommended as a long-term (i.e., longer than 2…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 60219-1467

What is NDC 60219-1467?: 60219-1467 is the product NDC for Medroxyprogesterone Acetate, Medroxyprogesterone acetate 150 mg/mL injection, suspension, listed with the FDA by Amneal Pharmaceuticals NY LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Medroxyprogesterone Acetate.
What is the active ingredient?: Medroxyprogesterone acetate.
Who is the labeler?: Amneal Pharmaceuticals NY LLC, NDC labeler code 60219. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Medroxyprogesterone Acetate?: 39 other product NDCs are listed under this name. See all Medroxyprogesterone Acetate NDCs.
Is there a related HCPCS / J-code?: Yes: J1050, Injection, medroxyprogesterone acetate, 1 mg. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Medroxyprogesterone Acetate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Medroxyprogesterone Acetate	Medroxyprogesterone acetate 2.5 mg/1	TabletOral	REMEDYREPACK INC.	70518-4666	70518-4666-0070518-4666-02
medroxyprogesterone acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	REMEDYREPACK INC.	70518-4324	70518-4324-00
Medroxyprogesterone Acetate	Medroxyprogesterone acetate 2.5 mg/1	TabletOral	Coupler LLC	67046-1480	67046-1480-03
Medroxyprogesterone Acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	Xiromed LLC	70700-315	70700-0315-2570700-0315-27
Medroxyprogesterone Acetate	Medroxyprogesterone acetate 10 mg/1	TabletOral	Northwind Health Company, LLC	51655-520	51655-0520-52
medroxyprogesterone acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	Amneal Pharmaceuticals LLC	70121-1467	70121-1467-0270121-1467-05
medroxyprogesterone acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	Amneal Pharmaceuticals LLC	70121-1480	70121-1480-01
Medroxyprogesterone Acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	Eugia US LLC	55150-330	55150-0330-01
Medroxyprogesterone Acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	Eugia US LLC	55150-329	55150-0329-0155150-0329-25
Medroxyprogesterone Acetate	Medroxyprogesterone acetate 5 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-8112	68788-8112-0168788-8112-03

All 40 Medroxyprogesterone Acetate NDCs

Other NDCs under ANDA 210227

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210227
Product	Strength	Form · route	Labeler	Product NDC
Medroxyprogesterone Acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	Mylan Institutional LLC	67457-887
Medroxyprogesterone Acetate	Medroxyprogesterone acetate 150 mg/mL	Injection, SuspensionIntramuscular	Xiromed LLC	70700-315